Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Research Solutions (RSSS) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Research Solutions (RSSS) over the last 16 years, with Q3 2025 value amounting to $749387.0.

  • Research Solutions' Consolidated Net Income rose 1201.53% to $749387.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 15913.61%. This contributed to the annual value of $1.3 million for FY2025, which is 13217.74% up from last year.
  • As of Q3 2025, Research Solutions' Consolidated Net Income stood at $749387.0, which was up 1201.53% from $2.4 million recorded in Q2 2025.
  • Over the past 5 years, Research Solutions' Consolidated Net Income peaked at $2.4 million during Q2 2025, and registered a low of -$3.0 million during Q2 2024.
  • Moreover, its 5-year median value for Consolidated Net Income was -$53628.0 (2023), whereas its average is -$175227.4.
  • In the last 5 years, Research Solutions' Consolidated Net Income skyrocketed by 18573.45% in 2023 and then crashed by 359253.75% in 2024.
  • Over the past 5 years, Research Solutions' Consolidated Net Income (Quarter) stood at -$481585.0 in 2021, then surged by 46.94% to -$255530.0 in 2022, then skyrocketed by 79.01% to -$53628.0 in 2023, then crashed by 3592.54% to -$2.0 million in 2024, then skyrocketed by 137.84% to $749387.0 in 2025.
  • Its last three reported values are $749387.0 in Q3 2025, $2.4 million for Q2 2025, and $216470.0 during Q1 2025.